We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

QLT Liable For Unfair Trade In Visudyne Litigation

Law360 (November 7, 2006, 12:00 AM EST) -- A federal jury has found biopharmaceutical company QLT Inc. liable for unjust enrichment and unfair trade practices but not liable for trade secret misappropriation in a countersuit brought by the Massachusetts Ear and Eye Infirmary over eye treatment Visudyne.

The jury handed down the decision on Monday, awarding MEEI a royalty of 3.01% on the net sales of Visudyne. Net sales of the treatment from its launch in 2000 to the end of the past Sept. totaled $2.2 billion worldwide, according to QLT, but it is...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.